These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.


  • J0013

    Esketamine, nasal spray, 1 mg
  • J0120

    Injection, tetracycline, up to 250 mg
  • J0121

    Injection, omadacycline, 1 mg
  • J0122

    Injection, eravacycline, 1 mg
  • J0129

    Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J0130

    Injection abciximab, 10 mg
  • J0131

    Injection, acetaminophen, not otherwise specified,10 mg
  • J0132

    Injection, acetylcysteine, 100 mg
  • J0133

    Injection, acyclovir, 5 mg
  • J0134

    Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg


  • Continued
  • J0135

    Injection, adalimumab, 20 mg
  • J0136

    Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
  • J0137

    Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
  • J0138

    Injection, acetaminophen 10 mg and ibuprofen 3 mg
  • J0139

    Injection, adalimumab, 1 mg
  • J0150

    Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
  • J0151

    Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
  • J0153

    Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
  • J0162

    Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg
  • J0163

    Injection, epinephrine in sodium chloride (endo), 0.1 mg
  • J0164

    Injection, epinephrine in sodium chloride (baxter), 0.1 mg
  • J0165

    Injection, epinephrine, not otherwise specified, 0.1 mg
  • J0166

    Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg
  • J0167

    Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg
  • J0168

    Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg
  • J0169

    Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg
  • J0171

    Injection, adrenalin, epinephrine, 0.1 mg
  • J0172

    Injection, aducanumab-avwa, 2 mg
  • J0173

    Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg
  • J0174

    Lecanemab-irmb, for intravenous injection, 1 mg


  • Continued
  • J0175

    Injection, donanemab-azbt, 2 mg
  • J0177

    Injection, aflibercept hd, 1 mg
  • J0178

    Injection, aflibercept, 1 mg
  • J0179

    Injection, brolucizumab-dbll, 1 mg
  • J0180

    Injection, agalsidase beta, 1 mg
  • J0184

    Injection, amisulpride, 1 mg
  • J0185

    Injection, aprepitant, 1 mg
  • J0190

    Injection, biperiden lactate, per 5 mg
  • J0200

    Injection, alatrofloxacin mesylate, 100 mg
  • J0202

    Injection, alemtuzumab, 1 mg
  • J0205

    Injection, alglucerase, per 10 units
  • J0206

    Injection, allopurinol sodium, 1 mg
  • J0207

    Injection, amifostine, 500 mg
  • J0208

    Injection, sodium thiosulfate (pedmark), 100 mg
  • J0209

    Injection, sodium thiosulfate (hope), 100 mg
  • J0210

    Injection, methyldopate hcl, up to 250 mg
  • J0211

    Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
  • J0215

    Injection, alefacept, 0.5 mg
  • J0216

    Injection, alfentanil hydrochloride, 500 micrograms
  • J0217

    Injection, velmanase alfa-tycv, 1 mg